Source:http://linkedlifedata.com/resource/pubmed/id/15084636
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2004-4-15
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1532-3
|
| pubmed:dateRevised |
2006-4-24
|
| pubmed:meshHeading |
pubmed-meshheading:15084636-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15084636-Bleomycin,
pubmed-meshheading:15084636-Dacarbazine,
pubmed-meshheading:15084636-Doxorubicin,
pubmed-meshheading:15084636-Hodgkin Disease,
pubmed-meshheading:15084636-Humans,
pubmed-meshheading:15084636-Vinblastine
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
|
| pubmed:publicationType |
Letter
|